Literature DB >> 31707557

Journey for patients following ileostomy creation is not straightforward.

Dedrick Kok Hong Chan1,2, Jingyu Ng3, Frederick Hong-Xiang Koh1, Tianzhi Lim1, Danson Yeo4, Kok-Yang Tan4, Ker-Kan Tan5,6.   

Abstract

BACKGROUND: An ileostomy is usually created to avert systemic sepsis in a patient with a tenuous anastomosis. However, what is often not reported are the numerous issues facing these patients subsequently, ranging from readmissions, non-reversal of the stoma, and complications from the closure. This study was performed to identify these issues among patients following creation of an ileostomy.
METHODS: We conducted a retrospective analysis of consecutive patients who had an ileostomy created from January 2011 to December 2016 at two institutions. Statistical analysis was performed to identify risk factors associated with readmissions and ileostomy non-reversal.
RESULTS: In total, 193 patients had an ileostomy created during the study period. Twenty-six (13.5%) patients developed stoma-related complications requiring readmission. The most common cause of readmission (9.3%) was due to dehydration and acute kidney injury secondary to high stoma output. One hundred thirty (67.4%) patients had their ileostomy reversed. On multivariate analysis, only stomas created during an ultra-low anterior resection were associated with reversal (OR 2.88 [95% CI, 1.24-6.68]; p = 0.014). Among the patients who underwent ileostomy reversal, seven (3.6%) patients developed complications from their ileostomy reversal. Four patients (2.1%) suffered from an anastomotic leak which required repeat surgical intervention with one mortality from the ensuing sepsis.
CONCLUSION: Almost half of the patients who had an Ileostomy had an undesirable outcome, including readmissions, non-reversal, and post-operative complications following closure. Patients need to be properly counselled about the risks involved prior to the index operation.

Entities:  

Keywords:  Complications; Ileostomy; Reversal

Mesh:

Year:  2019        PMID: 31707557     DOI: 10.1007/s00384-019-03428-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  13 in total

1.  Loop ileostomy reversal after colon and rectal surgery: a single institutional 5-year experience in 944 patients.

Authors:  Gaetano Luglio; Rajesh Pendlimari; Stefan D Holubar; Robert R Cima; Heidi Nelson
Journal:  Arch Surg       Date:  2011-10

2.  Protective defunctioning stoma in low anterior resection for rectal carcinoma.

Authors:  I Gastinger; F Marusch; R Steinert; S Wolff; F Koeckerling; H Lippert
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

3.  Racial Disparities After Stoma Construction Exist in Time to Closure After 1 Year but Not in Overall Stoma Reversal Rates.

Authors:  Drew J Gunnells; Lauren N Wood; Lauren Goss; Melanie S Morris; Gregory D Kennedy; Jamie A Cannon; Daniel I Chu
Journal:  J Gastrointest Surg       Date:  2017-07-28       Impact factor: 3.452

4.  Low complication rate after stoma closure. Consultants attended 90% of the operations.

Authors:  L Faunø; C Rasmussen; K K Sloth; A M Sloth; A Tøttrup
Journal:  Colorectal Dis       Date:  2012-08       Impact factor: 3.788

5.  Impact of surgical proficiency levels on postoperative morbidity: a single centre analysis of 558 ileostomy reversals.

Authors:  S Löb; K Luetkens; K Krajinovic; A Wiegering; C-T Germer; F Seyfried
Journal:  Int J Colorectal Dis       Date:  2018-03-13       Impact factor: 2.571

6.  Readmission for dehydration or renal failure after ileostomy creation.

Authors:  Ian M Paquette; Patrick Solan; Janice F Rafferty; Martha A Ferguson; Bradley R Davis
Journal:  Dis Colon Rectum       Date:  2013-08       Impact factor: 4.585

7.  Factors associated with hospital readmission following diverting ileostomy creation.

Authors:  W Li; L Stocchi; D Cherla; G Liu; A Agostinelli; C P Delaney; S R Steele; E Gorgun
Journal:  Tech Coloproctol       Date:  2017-08-17       Impact factor: 3.781

Review 8.  The Role of Temporary Fecal Diversion.

Authors:  Amy L Lightner; John H Pemberton
Journal:  Clin Colon Rectal Surg       Date:  2017-05-22

9.  Dehydration is the most common indication for readmission after diverting ileostomy creation.

Authors:  Evangelos Messaris; Rishabh Sehgal; Susan Deiling; Walter A Koltun; David Stewart; Kevin McKenna; Lisa S Poritz
Journal:  Dis Colon Rectum       Date:  2012-02       Impact factor: 4.585

10.  Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease.

Authors:  Linda Li; Kelsey S Lau; Venkat Ramanathan; Sonia T Orcutt; Shubhada Sansgiry; Daniel Albo; David H Berger; Daniel A Anaya
Journal:  J Surg Res       Date:  2016-11-29       Impact factor: 2.192

View more
  4 in total

1.  Predisposing factors and clinical impact of high-output syndrome after sphincter-preserving surgery with covering ileostomy for rectal cancer: a retrospective single-center cohort study.

Authors:  Ryota Nakanishi; Tsuyoshi Konishi; Erika Nakaya; Yoko Zaitsu; Toshiki Mukai; Tomohiro Yamaguchi; Toshiya Nagasaki; Takashi Akiyoshi; Satoshi Nagayama; Yosuke Fukunaga
Journal:  Int J Clin Oncol       Date:  2020-09-09       Impact factor: 3.402

2.  Short stump and high anastomosis pull-through (SHiP) procedure for delayed coloanal anastomosis with no protective stoma for low rectal cancer.

Authors:  Francesco Bianco; Paola Incollingo; Armando Falato; Silvia De Franciscis; Andrea Belli; Fabio Carbone; Gaetano Gallo; Mario Fusco; Giovanni Maria Romano
Journal:  Updates Surg       Date:  2021-03-16

3.  Risk factors and outcomes associated with postoperative ileus following ileostomy formation: a retrospective study.

Authors:  Anya L Greenberg; Yvonne M Kelly; Rachel E McKay; Madhulika G Varma; Ankit Sarin
Journal:  Perioper Med (Lond)       Date:  2021-12-13

4.  Assessment of the risk of permanent stoma after low anterior resection in rectal cancer patients.

Authors:  Marcin Zeman; Marek Czarnecki; Andrzej Chmielarz; Adam Idasiak; Maciej Grajek; Agnieszka Czarniecka
Journal:  World J Surg Oncol       Date:  2020-08-14       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.